Trial Profile
Subcutaneous Immunoglobulin With rHuPH20 in Multifocal Motor Neuropathy
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 05 Nov 2021
Price :
$35
*
At a glance
- Drugs Immune globulin (Primary) ; Hyaluronidase
- Indications Multifocal motor neuropathy
- Focus Adverse reactions
- Acronyms Hymne
- 29 Jul 2016 New trial record